-
The Brain Tumour Charity asked to lead on discussions around biobanking and early diagnosis
On Monday The Brain Tumour Charity attended the second meeting of the task and finish working group on research into brain tumour (TFWG) which was set up by the Department of Health to address barriers to research.
-
What Brexit means for research into brain tumours
Policy Officer, James Thorneycroft, discusses how leaving the EU could affect research into brain tumours.
-
Scientists find unlikely ally in Salmonella to target brain tumour cells
The cause behind millions of cases of food poisoning has been surprisingly effective in crossing the blood brain barrier to reach tumour sites. Researchers at Duke University genetically modified the bacteria Salmonella to enable it to seek out and attack glioblastoma tumour cells in animal models.
-
Targeting DNA repair protein for the treatment of glioblastoma
Scientists at the University of Leeds have discovered that targeting a protein that helps cancer cells repair their DNA could lead to a new treatment for the highly aggressive brain tumour, glioblastoma (GBM).
-
Mum thanks HeadSmart after son’s brain tumour diagnosis
Claire Lloyd came across our HeadSmart website, which lists the most common signs of childhood brain tumours, after her nine-year-old son Jack had been vomiting regularly during the day for more than a week.
-
Laying the foundations for more effective brain tumour treatments
David Jenkinson, Chief Scientific Officer at The Brain Tumour Charity, discusses laying foundations for more effective brain tumour treatments.
-
HeadSmart campaign launches new website and drive to further reduce childhood brain tumour diagnosis times
HeadSmart has already helped cut the average diagnosis time for a childhood brain tumour in the UK from more than 13 weeks to 6.5 weeks.
-
Immunotherapy and gene therapy double attack against glioblastoma shows therapeutic potential
A combinatorial approach using immunotherapy and gene therapy has been explored by researchers at the University of Michigan against the highly aggressive brain tumour, glioblastoma (GBM).
-
Working with NHS England to improve access to Clinical Nurse Specialists
The Brain Tumour Charity have collaborated with NHS England to better understand the role of Clinical Nurse Specialists (CNS) and Keyworkers who work with people affected by brain tumours.
-
Our meeting with the DVLA and the changes announced
In response to overwhelming concerns from our community The Brain Tumour Charity met with the Driver and Vehicle Licensing Agency (DVLA) in Swansea to discuss issues around driving and brain tumours.
-
Exploiting metabolic pathways used by glioblastoma cells to halt tumour growth
A team at The Scripps Research Institute, USA, have been able to identify a cellular pathway used by glioblastoma (GBM) tumours to allow them to survive, that could be exploited therapeutically to halt tumour growth.
-
Grace’s vlog: documenting life with a brain tumour
Grace, 23, recently filmed her first video blog for us where she asked our community for any questions about diagnosis, symptoms and effects and life after surgery. Her honest and heartfelt answers are now documented in a video diary.
-
Our ambitions exceed those of Cancer Research UK
A report today from Cancer Research UK predicts that survival from brain tumours will remain virtually unchanged over the next 20 years, despite an expected fall of 15% overall in the number of cancer deaths by 2035.
-
A research round-up from Dr Paul Brennan at the University of Edinburgh
Dr Paul Brennan, from the University of Edinburgh, shares a round-up of his research with us.
-
We are hosting the biobanking workshop initiative in London today
The Biobanking Consensus Meeting, initiated by us, is being held at Islington’s Business Design Centre in London.
-
Canadian researchers discover cell subgroups in treatment of paediatric ATRT brain cancer
Researchers from Toronto and Montreal have successfully identified three distinct sub-groups of classification of the incurable typical teratoid rhabdoid tumours (ATRTs).
-
Brain tumour patients denied life-extending drug in ‘postcode lottery’
A drug that can extend the lives of brain tumour patients is being withheld by some NHS Trusts on the grounds of cost.
-
We are proud to announce the formation of our Scientific Advisory Boards
In order to ensure that we fund only the highest quality research, we have formed two Scientific Advisory Boards (SABs) which are made up of internationally renowned scientific and medical experts that work in different areas of cancer research and social science.
-
Research into brain tumours: why money isn’t everything
Beccy Shortt, our Senior Policy and Public Affairs Manager at The Brain Tumour Charity explores the barriers surrounding brain tumour research.
-
New biomarker could improve the diagnosis of diffuse gliomas
Researchers at the University of Texas Southwestern Medical Center in Dallas have identified a gene called SHOX2 that could be used to better diagnose brain tumours.
-
Why we’re investing in new brain tumour fund
“We will always do things differently if it’s the right thing for people affected by a brain tumour. That’s why we’re investing in The Brain Tumour Fund.” – Sarah Lindsell, CEO of The Brain Tumour Charity
-
Julien Baptiste in the BBC One drama The Missing, sheds light on effects of a brain tumour diagnosis
Julien Baptiste’s character, played by acclaimed actor Tchéky Karyo, steered the second series of the award-winning drama with the diagnosis of a brain tumour framing his actions and decisions as a key aspect of the storyline.
-
Headeast Vietnam cycle challenge battle first day typhoon
Lewis Moody MBE, co-Founder of The Foundation and headeast organiser, polar explorer Alan Chambers MBE and 10 other fearless cycling challengers have saddled up in Saigon.
-
Edinburgh research discovers new relationship between immune and glioblastoma cells
Research carried out at the University of Edinburgh has revealed a new alliance between immune cells and glioblastoma tumour cells in zebrafish.